Plasma-Free Strategy for Cardiac Surgery with Cardiopulmonary Bypass in Infants < 10 kg: A Retrospective, Propensity-Matched Study

• Published in: Journal of clinical medicine Vol. 12; no. 12; p. 3907
• Main Authors: Ranucci, Marco, Di Dedda, Umberto, Isgrò, Giuseppe, Giamberti, Alessandro, Cotza, Mauro, Cornara, Noemi, Baryshnikova, Ekaterina
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 07-06-2023; MDPI
• Subjects: Blood products; Children; Clinical medicine; Coronary artery bypass; Demographic aspects; Evaluation; Heart surgery; Methods; Patients; Surgeons; Surgery; Surgical apparatus & instruments; Italy; fresh frozen plasma; pediatric cardiac surgery; postoperative bleeding; plasma-free strategy; transfusions
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12123907

Infants < 10 kg undergoing cardiac surgery with cardiopulmonary bypass (CPB) may receive either fresh frozen plasma (FFP) or other solutions in the CPB priming volume. The existing comparative studies are controversial. No study addressed the possibility of total avoidance of FFP throughout the whole perioperative course in this patient population. This retrospective, non-inferiority, propensity-matched study investigates an FFP-free strategy compared to an FFP-based strategy.
Among patients <10 kg with available viscoelastic measurements, 18 patients who received a total FFP-free strategy were compared to 27 patients (1:1.5 propensity matching) receiving an FFP-based strategy. The primary endpoint was chest drain blood loss in the first 24 postoperative hours. The level of non-inferiority was settled at a difference of 5 mL/kg.
The 24-h chest drain blood loss difference between groups was -7.7 mL (95% confidence interval -20.8 to 5.3) in favor of the FFP-based group, and the non-inferiority hypothesis was rejected. The main difference in coagulation profile was a lower level of fibrinogen concentration and FIBTEM maximum clot firmness in the FFP-free group immediately after protamine, at the admission in the ICU and for 48 postoperative hours. No differences in transfusion of red blood cells or platelet concentrate were observed; patients in the FFP-free group did not receive FFP but required a larger dose of fibrinogen concentrate and prothrombin complex concentrate.
An FFP-free strategy in infants < 10 kg operated with CPB is technically feasible but results in an early post-CPB coagulopathy that was not completely compensated with our bleeding management protocol.